Skip to Main Content

Paper Details

The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.
BMC Cancer
16
2022
Author NameAffiliation
David J AdamsWellcome Sanger Institute
  • 1 - 1

Datasets

BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink
BioSamples databaseBioSamples database: FAIRer samples metadata to accelerate research data maLink